Kalbe Farma to place USD 10 million investment in Progen
17 Jan 2023 06:37
PT Kalbe Farma Tbk (KLBF), a pharmaceutical company, has made an investment worth USD 10 million in Progen Co. Ltd. to enhance the collaboration of research and development (R&D) in biological drugs.